🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs
5,427

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Page 31 of 114

  1. Elenestinib

    Blueprint Medicines (Netherlands) B.V.

    Indolent Systemic Mastocytosis

    phase 3 small molecule active

    1 trial

  2. Eligard 22,5 mg poeder en oplosmiddel voor oplossing voor injectie

    Disc Medicine

    Patients with biochemical recurrence after primary treatment of prostate cancer presenting with =<4 metastases

    phase 3 small molecule active

    1 trial

  3. Eliglustat, Cerezyme 400 Units Powder for concentrate for solution for infusion, Cerezyme 400 Units Powder for concentrate for solution for infusion, Eliglustat, Eliglustat, Cerezyme 400 Units Powder for concentrate for solution for infusion, Eliglustat

    Genzyme Europe B.V.

    Gaucher's disease type I; Gaucher's disease type III

    phase 3 small molecule active

    1 trial

  4. Eliquis 5 mg film-coated tablets, ACETYLSALICYLIC ACID

    Pari Pharma GmbH

    Aortic bioprothesis implanted patient for valvular heart disease

    phase 3 small molecule active

    1 trial

  5. Eloralintide

    Eli Lilly and Company

    Obesity

    phase 3 small molecule active

    1 trial

  6. Eloralintide, Eloralintide, Eloralintide, Placebo to match LY, Eloralintide

    Eli Lilly Co.

    Overweight, Obesity, Sleep Apnea, Obstructive

    phase 3 small molecule active

    1 trial

  7. Eloralintide, Eloralintide, Placebo to match LY, Eloralintide, Eloralintide

    Eli Lilly Co.

    Overweight, Obesity

    phase 3 small molecule active

    1 trial

  8. Eloralintide, Placebo to match LY, Eloralintide, Eloralintide, Eloralintide

    Eli Lilly Co.

    Obesity, Overweight

    phase 3 small molecule active

    1 trial

  9. Elritercept

    Takeda

    Myelodysplastic Syndrome

    phase 3 small molecule active

    1 trial

  10. Eltrombopag

    GlaxoSmithKline

    Non-alcoholic Steatohepatitis

    phase 3 small molecule terminated

    1 trial

  11. Eltrombopag 25 MG Oral Tablet

    The First People's Hospital of Lianyungang

    Stem Cell Transplant Complications

    phase 3 small molecule completed

    1 trial

  12. Emicizumab

    Takeda

    Hemophilia A

    phase 3 small molecule active

    1 trial

  13. Emixustat

    BRIGHT MINDS BIOSCIENCES INC.

    Stargardt Disease

    phase 3 small molecule completed

    1 trial

  14. Empagliflozin

    Boehringer Ingelheim

    Chronic Kidney Disease

    phase 3 small molecule active

    1 trial

  15. Empagliflozin

    Boehringer Ingelheim

    Myocardial Infarction

    phase 3 small molecule completed

    1 trial

  16. Empagliflozin

    Boehringer Ingelheim

    Heart Failure

    phase 3 small molecule completed

    1 trial

  17. Empagliflozin 10 MG

    COLLEGIUM PHARMACEUTICAL, INC

    Acute Decompensated Heart Failure

    phase 3 small molecule active

    1 trial

  18. Empagliflozin 10 MG

    Hospital Authority, Hong Kong

    Diabetic Nephropathies

    phase 3 small molecule terminated

    1 trial

  19. Empagliflozin 10 mg

    United Therapeutics Europe Ltd

    Acute Myocardial Infarction

    phase 3 small molecule completed

    1 trial

  20. Empagliflozin 20 mg

    COLLEGIUM PHARMACEUTICAL, INC

    Metabolic Syndrome

    phase 3 small molecule active

    1 trial

  21. Empliciti 400 mg powder for concentrate for solution for infusion., DARZALEX 1800 mg solution for injection, Alnuctamab, Imnovid 2 mg hard capsules, Alnuctamab, Imnovid 3 mg hard capsules, Imnovid 1 mg hard capsules, Kyprolis 60 mg powder for solution for infusion, Fortecortin® Inject 8 mg Injektionslösung in einer Ampulle, DEXAMETHASONE, Imnovid 4 mg hard capsules

    Celgene Europe Limited

    Relapsed and/or Refractory Multiple Myeloma

    phase 3 small molecule active

    1 trial

  22. Empowered Relief On-Demand

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    phase 3 other completed

    1 trial

  23. Enbrel 50 mg solution for injection in pre-filled syringe, Enbrel 50 mg solution for injection in pre-filled syringe

    Mabxience Research SL

    Rheumatoid Arthritis

    phase 3 small molecule active

    1 trial

  24. Enbrel 50 mg solution for injection in pre-filled syringe, Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL, Guselkumab 1 mL PFS Placebo, Guselkumab, Guselkumab 0.5 mL Varioject Placebo, Enbrel 25 mg powder and solvent for solution for injection

    Janssen-Cilag International N.V.

    Chronic Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  25. Encaleret

    BridgeBio Oncology Therapeutics

    Autosomal Dominant Hypocalcemia (ADH)

    phase 3 small molecule active

    2 trials

  26. Encaleret

    BridgeBio Oncology Therapeutics

    Autosomal Dominant Hypocalcemia Type 1 (ADH1)

    phase 3 small molecule active

    1 trial

  27. Endoscopic submucosal dissection

    United Therapeutics Europe Ltd

    Colorectal Neoplasms

    phase 3 other active

    1 trial

  28. Endoscopic submucosal dissection

    Chinese University of Hong Kong

    Colorectal Neoplasms

    phase 3 other active

    1 trial

  29. Endostar

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  30. Endoxifen, Identical placebo tablets of Endoxifen manufactured by Intas Pharmaceuticals Limited, India. The placebo tablets were manufactured using the same excipients and the manufacturing process of endoxifen tablets. Like endoxifen 8 mg tablets, the placebo tablets are green coloured, round shape, biconvex, enteric coated tablets plain on both sides. The placebo for Endoxifen Tablets 8 mg was manufactured following the same procedure as the drug product without using endoxifen citrate.

    Lacuna Pharma Pty Ltd

    Bipolar I Disorder

    phase 3 small molecule active

    1 trial

  31. Enema transplant of fecal microbiota, Placebo Enema transplant of fecal microbiota

    Pari Pharma GmbH

    Adult patients with ulcerative colitis diagnosed for at least 3 months

    phase 3 small molecule active

    1 trial

  32. Enhanced care

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Addiction

    phase 3 other completed

    1 trial

  33. Enhanced standard management

    United Therapeutics Europe Ltd

    Pacemaker Complication

    phase 3 other active

    1 trial

  34. Enoxaparin

    Bristol-Myers Squibb

    Deep Vein Thrombosis

    phase 3 small molecule completed

    1 trial

  35. Enoxaparin sodium (XRP4563)

    Sanofi Pasteur

    Myocardial Infarction

    phase 3 small molecule completed

    1 trial

  36. Entecavir

    Bristol-Myers Squibb

    Hepatitis B, Chronic

    phase 3 small molecule completed

    1 trial

  37. Entecavir

    Hoffmann-La Roche

    Pediatric Immuno-Tolerant Chronic Hepatitis B

    phase 3 small molecule completed

    1 trial

  38. Entyvio 108 mg solution for injection in pre-filled syringe, Entyvio 108 mg solution for injection in pre-filled pen

    Takeda

    Ulcerative Colitis or Crohn’s Disease

    phase 3 small molecule active

    1 trial

  39. Entyvio 108 mg solution for injection in pre-filled syringe, Entyvio 300 mg powder for concentrate for solution for infusion

    Takeda

    Active Ulcerative Colitis or Crohn’s Disease

    phase 3 small molecule active

    1 trial

  40. Enzalutamide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Metastatic Hormone Sensitive Prostate Cancer

    phase 3 small molecule active

    1 trial

  41. Enzastaurin

    AYTU BIOPHARMA, INC

    Vascular Ehlers-Danlos Syndrome

    phase 3 small molecule on hold

    1 trial

  42. Epcoritamab (GEN3013), Revlimid 5 mg hard capsules, Revlimid 20 mg hard capsules, Epcoritamab (GEN3013), Truxima 500 mg concentrate for solution for infusion, Truxima 100 mg concentrate for solution for infusion

    AbbVie Deutschland GmbH & Co. KG

    Relapsed and Refractory Follicular Lymphoma

    phase 3 small molecule active

    1 trial

  43. Epetraborole

    AN2 Therapeutics

    MAC Lung Disease

    phase 3 small molecule terminated

    1 trial

  44. Epidyolex 100 mg/ml oral solution

    Lacuna Pharma Pty Ltd

    Dravet Syndrome, Tuberous sclerosis complex, Lennox-Gastaut Syndrome

    phase 3 small molecule active

    1 trial

  45. Epinephrine

    Chinese University of Hong Kong

    Gastric Neoplasm

    phase 3 small molecule completed

    1 trial

  46. Epinephrine HFA-MDI (E004)

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    1 trial

  47. Epirubicin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 3 small molecule active

    1 trial

  48. Eplerenone

    Pfizer

    Hypertension

    phase 3 small molecule completed

    2 trials

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.